Built on a solid knowledge platform

Xinnate is built on more than 15 years of world class research by professor Artur Schmidtchen and his team at Lund University.  Xinnate operates in close cooperation with Professor Schmidtchen with the aim to further develop and commercialize the proprietary novel peptide platform, BioC, in the areas of skin and wounds, surgery and biomaterials.

The mode of action of BioC is well investigated and understood, and there is a proven positive effect of BioC on infection and wound healing.

Link to list of publications

Read more about: